Prognostic value of BRAF mutations in localized cutaneous melanoma

Journal of the American Academy of Dermatology

Volumn 70, Issue 5, 2014, Pages

  Nagore, Eduardo ^a,b   Requena, Celia ^a   Traves, Víctor ^a   Guillen, Carlos ^a   Hayward, Nicholas K ^c   Whiteman, David C ^c   Hacker, Elke ^c,d  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

BRAF; localized; melanoma; NRAS; prognosis; survival

Indexed keywords

B RAF KINASE;

ADULT; AGE; AGED; ARTICLE; BRESLOW THICKNESS; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CUTANEOUS MELANOMA; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MITOSIS RATE; OBSERVATIONAL STUDY; ONCOGENE N RAS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX; SKIN ULCER; SKINFOLD THICKNESS; TUMOR LOCALIZATION; WILD TYPE;

BRAF; LOCALIZED; MELANOMA; NRAS; PROGNOSIS; SURVIVAL;

DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; MELANOMA; MUTATION; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84899053870     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.10.064     Document Type: Article

References (18)

1. J.A. Curtin, J. Fridlyand, T. Kageshita, H.N. Patel, K.J. Busam, and H. Kutzner et al. Distinct sets of genetic alterations in melanoma N Engl J Med 353 2005 2135 2147
2. J.A. Curtin, K. Busam, D. Pinkel, and B.C. Bastian Somatic activation of KIT in distinct subtypes of melanoma J Clin Oncol 24 2006 4340 4346
3. M.T. Landi, J. Bauer, R.M. Pfeiffer, D.E. Elder, B. Hulley, and P. Minghetti et al. MC1R germline variants confer risk for BRAF-mutant melanoma Science 313 2006 521 522
4. N.E. Thomas, S.N. Edmiston, A. Alexander, R.C. Millikan, P.A. Groben, and H. Hao et al. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma Cancer Epidemiol Biomarkers Prev 16 2007 991 997
5. J. Bauer, P. Buttner, R. Murali, I. Okamoto, N.A. Kolaitis, and M.T. Landi et al. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site Pigment Cell Melanoma Res 24 2011 345 351
6. J.A. Ellerhorst, V.R. Greene, S. Ekmekcioglu, C.L. Warneke, M.M. Johnson, and C.P. Cooke et al. Clinical correlates of NRAS and BRAF mutations in primary human melanoma Clin Cancer Res 17 2010 229 235
7. E. Hacker, E. Nagore, L. Cerroni, S.L. Woods, N.K. Hayward, and B. Chapman et al. NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations J Invest Dermatol 133 2013 1027 1033
8. A. Viros, J. Fridlyand, J. Bauer, K. Lasithiotakis, C. Garbe, and D. Pinkel et al. Improving melanoma classification by integrating genetic and morphologic features PLoS Med 5 2008 e120
9. E. Edlundh-Rose, S. Egyhazi, K. Omholt, E. Mansson-Brahme, A. Platz, and J. Hansson et al. NRAS and BRAF mutations in melanoma tumors in relation to clinical characteristics: a study based on mutation screening by pyrosequencing Melanoma Res 16 2006 471 478
10. G.V. Long, A.M. Menzies, A.M. Nagrial, L.E. Haydu, A.L. Hamilton, and G.J. Mann et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma J Clin Oncol 29 2011 1239 1246
11. L. Si, Y. Kong, X. Xu, K.T. Flaherty, X. Sheng, and C. Cui et al. Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort Eur J Cancer 48 2012 94 100
12. H. El-Osta, G. Falchook, A. Tsimberidou, D. Hong, A. Naing, and K. Kim et al. BRAF mutations in advanced cancers: clinical characteristics and outcomes PloS One 6 2011 e25806
13. L.A. Akslen, S. Angelini, O. Straume, I.M. Bachmann, A. Molven, and K. Hemminki et al. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival J Invest Dermatol 125 2005 312 317
14. E. Nagore, R. Botella-Estrada, C. Requena, C. Serra-Guillen, A. Martorell, and L. Hueso et al. Clinical and epidemiologic profile of melanoma patients according to sun exposure of the tumor site [in Spanish] Acta Dermosifiliogr 100 2009 205 211
15. E. Nagore, C. Pereda, R. Botella-Estrada, C. Requena, and C. Guillen Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility Cancer Causes Control 20 2009 115 119
16. E. Hacker, N.K. Hayward, T. Dumenil, M.R. James, and D.C. Whiteman The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population J Invest Dermatol 130 2010 241 248
17. M.C. Fargnoli, K. Pike, R.M. Pfeiffer, S. Tsang, E. Rozenblum, and D.J. Munroe et al. MC1R variants increase risk of melanomas harboring BRAF mutations J Invest Dermatol 128 2008 2485 2490
18. D. Scherer, P.S. Rachakonda, S. Angelini, F. Mehnert, A. Sucker, and F. Egberts et al. Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors J Invest Dermatol 130 2010 2844 2848